KUMC Policies |
Revised |
|
PDF |
||
 |
SOP
1.0 HSC Authority and Institutional Commitment |
July 2010 |
|
|
SOP
2.0 Initial Review Procedures |
Februrary 2010 | |
SOP
3.0 HSC Relation to Other KUMC Committees |
Februrary 2010 |
|
SOP
4.0 Privacy and Confidentiality |
Februrary 2010 | |
SOP
5.0 Reviews of Ongoing Research |
Februrary 2010 | |
SOP
6.0 Continuing Review Procedures |
Februrary 2010 | |
SOP 7.0 Informed Consent Requirements |
Februrary 2010 | |
SOP
8.0 Selection and Recruitment of Subjects |
Februrary 2010 | |
SOP
9.0 Vulnerable Populations |
Februrary 2010 | |
SOP
10.0 Research with Human Biologic Material |
Februrary 2010 |
|
SOP
11.0 FDA-Regulated Research |
Februrary 2010 | |
SOP
12.0 Social and Behavioral Research |
Februrary 2010 | |
SOP
13.0 Collaborative Research |
Februrary 2010 | |
SOP
14.0 Investigator Responsibilities |
Februrary 2010 |
|
SOP
15.0 Education and Training in Human Research
Protections |
Februrary 2010 | |
SOP 17.0 Institutional Responsibilities | Februrary 2010 |  |
Research
Records Retention Policy |
January 2008 |
|
Policy
on Research with Coded or De-identified Data/Specimens |
November 1, 2004 |
Federal Regulations and Guidelines |
DHHS
Protection of Human Subjects (The Common Rule) 45 CFR 46 |
| FDA
Regulations on Protection of Human Subjects 21 CFR 50 |
||
| FDA
Regulations on Institutional Review Boards 21 CFR 56 |
||
| FDA
Regulations on Investigational New Drugs 21 CFR 312 |
||
| FDA
Regulations on Investigational Device Exemptions 21 CFR 812 |
||
| FDA
Regulations on Financial Disclosure by Clinical Investigators
21 CFR 54 |
||
| Federal
Wide Assurance |
||
| OHRP
Guidebook |
||
| FDA
Instruction Sheets |
||
| OHRP International Compilation of Human Subject Research Protections | ||
KUMC Wichita | Research Institute | Research Advisory Council
©
The University of Kansas Medical Center